China assesses illegal drug activities

Six departments within the Chinese government started a nationwide drug safety assessment this week, says the Ministry of Health. Goals include establishing order and curtailing illegal activity as well as stopping the manufacture and sale of counterfeit drugs. Story

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.